| Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia M Buchner, S Fuchs, G Prinz, D Pfeifer, K Bartholomé, M Burger, ... Cancer research 69 (13), 5424-5432, 2009 | 218 | 2009 |
| The resistance of B-CLL cells to DNA damage–induced apoptosis defined by DNA microarrays L Vallat, H Magdelénat, H Merle-Béral, P Masdehors, ... Blood 101 (11), 4598-4606, 2003 | 130 | 2003 |
| Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection L Vallat, Y Benhamou, M Gutierrez, P Ghillani, C Hercher, V Thibault, ... Arthritis & Rheumatism 50 (11), 3668-3678, 2004 | 127 | 2004 |
| Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes Y Vasconcelos, J De Vos, L Vallat, T Reme, AI Lalanne, K Wanherdrick, ... Leukemia 19 (11), 2002-2005, 2005 | 66 | 2005 |
| Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells LD Vallat, Y Park, C Li, JG Gribben Blood 109 (9), 3989-3997, 2007 | 64 | 2007 |
| Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring D Reita, L Pabst, E Pencreach, E Guérin, L Dano, V Rimelen, AC Voegeli, ... Cancers 13 (19), 4926, 2021 | 57 | 2021 |
| B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features O Guipaud, L Deriano, H Salin, L Vallat, L Sabatier, H Merle-Béral, J Delic The Lancet Oncology 4 (8), 506-514, 2003 | 57 | 2003 |
| BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo C Schleiss, W Ilias, O Tahar, Y Güler, L Miguet, C Mayeur-Rousse, ... Scientific reports 9 (1), 701, 2019 | 49 | 2019 |
| Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance D Reita, L Pabst, E Pencreach, E Guérin, L Dano, V Rimelen, AC Voegeli, ... Cancers 14 (5), 1321, 2022 | 39 | 2022 |
| Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma LM Fornecker, L Muller, F Bertrand, N Paul, A Pichot, R Herbrecht, ... Scientific reports 9 (1), 895, 2019 | 33 | 2019 |
| Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia L Vallat, CA Kemper, N Jung, M Maumy-Bertrand, F Bertrand, N Meyer, ... Proceedings of the National Academy of Sciences 110 (2), 459-464, 2013 | 33 | 2013 |
| A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia A Perrot, C Pionneau, S Nadaud, F Davi, V Leblond, F Jacob, ... Blood, The Journal of the American Society of Hematology 118 (4), e1-e15, 2011 | 30 | 2011 |
| Expression and proliferative effect of hemokinin-1 in human B-cells S Grassin-Delyle, A Buenestado, L Vallat, E Naline, S Marx, J Decocq, ... Peptides 32 (5), 1027-1034, 2011 | 24 | 2011 |
| Reduced DICER1 Expression Bestows Rheumatoid Arthritis Synoviocytes Proinflammatory Properties and Resistance to Apoptotic Stimuli G Alsaleh, R Nehmar, S Blüml, C Schleiss, E Ostermann, JP Dillenseger, ... Arthritis & Rheumatology 68 (8), 1839-1848, 2016 | 23 | 2016 |
| Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELBin an aggressive subset of chronic lymphocytic … JB Marteau, O Rigaud, T Brugat, N Gault, L Vallat, M Kruhoffer, TF Orntoft, ... BMC Medical Genomics 3, 1-15, 2010 | 19 | 2010 |
| Cascade: a R package to study, predict and simulate the diffusion of a signal through a temporal gene network N Jung, F Bertrand, S Bahram, L Vallat, M Maumy-Bertrand Bioinformatics 30 (4), 571-573, 2014 | 14 | 2014 |
| Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia C Schleiss, R Carapito, LM Fornecker, L Muller, N Paul, O Tahar, A Pichot, ... Leukemia 35 (5), 1463-1474, 2021 | 8 | 2021 |
| Genetic heterogeneity of the hypervariable region I of hepatitis C virus and lymphoproliferative disorders A Rigolet, P Cacoub, A Schnuriger, L Vallat, A Cahour, P Ghillani, F Davi, ... Leukemia 19 (6), 1070-1076, 2005 | 7 | 2005 |
| CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition A Galland, V Gourain, K Habbas, Y Güler, E Martin, C Ebel, M Tavian, ... Molecular oncology 15 (9), 2318-2329, 2021 | 6 | 2021 |
| Waldenström’s macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders A Perrot, C Pionneau, N Azar, C Baillou, FM Lemoine, V Leblond, ... Blood Cancer Journal 2 (9), e88-e88, 2012 | 6 | 2012 |
